Literature DB >> 18829577

Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

Kyung Song1, Hui Wang, Tracy L Krebs, Seong-Jin Kim, David Danielpour.   

Abstract

The androgen receptor cross-talks with transforming growth factor-beta (TGF-beta) through mechanisms that remain poorly understood. Here we provide strong evidence that 5alpha-dihydrotestosterone (DHT) intercepts the ability of prostate epithelial cells to undergo TGF-beta-induced apoptosis, and present a new model for this androgenic effect. We report that DHT decreases the level of TGF-beta receptor II (TbetaRII) through a transcriptional mechanism, leading to suppression of the ability of TGF-beta to down-regulate expression of Bcl-xL and cyclin Ds, activate caspase-3, and induce apoptosis. Promoter analysis, DNA pulldown, and electrophoretic mobility shift assays support that transcriptional down-regulation of TbetaRII by DHT occurs through Sp1/Sp3 response elements, with the binding of Sp1 to the TbetaRII promoter being suppressed by DHT, largely driven by loss of Sp1 protein and/or activity. These results provide fresh insight on the mechanism of growth control by androgens and the progression of prostate cancer to androgen independence. [Cancer Res 2008;68(19):8173-82].

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829577      PMCID: PMC2596934          DOI: 10.1158/0008-5472.CAN-08-2290

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Controlling TGF-beta signaling.

Authors:  J Massagué; Y G Chen
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  The Smad pathway.

Authors:  J L Wrana; L Attisano
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

3.  Improved purification and yields of RNA by RNeasy.

Authors:  M J Bonham; D Danielpour
Journal:  Biotechniques       Date:  1996-07       Impact factor: 1.993

4.  A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor.

Authors:  S G Choi; Y Yi; Y S Kim; M Kato; J Chang; H W Chung; K B Hahm; H K Yang; H H Rhee; Y J Bang; S J Kim
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

5.  Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.

Authors:  S D Kundu; I Y Kim; T Yang; L Doglio; S Lang; X Zhang; R Buttyan; S J Kim; J Chang; X Cai; Z Wang; C Lee
Journal:  Prostate       Date:  2000-05-01       Impact factor: 4.104

6.  The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.

Authors:  M S Lucia; M B Sporn; A B Roberts; L V Stewart; D Danielpour
Journal:  J Cell Physiol       Date:  1998-05       Impact factor: 6.384

7.  SMAD3 represses androgen receptor-mediated transcription.

Authors:  S A Hayes; M Zarnegar; M Sharma; F Yang; D M Peehl; P ten Dijke; Z Sun
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.

Authors:  M J Gerdes; T D Dang; M Larsen; D R Rowley
Journal:  Endocrinology       Date:  1998-08       Impact factor: 4.736

9.  Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression.

Authors:  I Y Kim; H J Ahn; D J Zelner; L Park; J A Sensibar; C Lee
Journal:  Mol Endocrinol       Date:  1996-01

10.  Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.

Authors:  Y Ko; S S Banerji; Y Liu; W Li; J Liang; H D Soule; R J Pauley; J K Willson; E Zborowska; M G Brattain
Journal:  J Cell Physiol       Date:  1998-08       Impact factor: 6.384

View more
  23 in total

1.  The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.

Authors:  Qi Jiang; Bang-Min Han; Fu-Jun Zhao; Yan Hong; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

2.  DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Bingcheng Wang; Thomas J Kelley; David Danielpour
Journal:  Mol Endocrinol       Date:  2010-08-25

3.  A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

Authors:  Eswar Shankar; Kyung Song; Sarah L Corum; Kara L Bane; Hui Wang; Hung-Ying Kao; David Danielpour
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

4.  Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.

Authors:  Reema S Wahdan-Alaswad; Kyung Song; Tracy L Krebs; Dorjee T N Shola; Jose A Gomez; Shigemi Matsuyama; David Danielpour
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

5.  The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.

Authors:  Margaretha van der Deen; Jacqueline Akech; Tao Wang; Thomas J FitzGerald; Dario C Altieri; Lucia R Languino; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

Review 6.  Stroma-epithelium crosstalk in prostate cancer.

Authors:  Yi-Nong Niu; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

7.  Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.

Authors:  Mikhail G Dozmorov; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Mark Barton Frank; Jeanette Osban; Trevor M Penning; Hsueh-Kung Lin
Journal:  Prostate       Date:  2009-07-01       Impact factor: 4.104

8.  Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.

Authors:  Hong Pu; Joanne Collazo; Elisabeth Jones; Dustin Gayheart; Shinichi Sakamoto; Adam Vogt; Bonnie Mitchell; Natasha Kyprianou
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

9.  N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice.

Authors:  Dai-Fei Shen; He Cheng; Bo-Zhi Cai; Wen-Feng Cai; Bin Wang; Qing Zhu; Yue-Bin Wu; Man Liu; Run-Ji Chen; Fen-Fei Gao; Yan-Mei Zhang; Yong-Dong Niu; Gang-Gang Shi
Journal:  Acta Pharmacol Sin       Date:  2021-03-23       Impact factor: 6.150

10.  The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development.

Authors:  Paul G Corn
Journal:  Cancer Manag Res       Date:  2012-07-25       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.